[Biotherapies for the treatment of asthma: are they the treatment of the future?].
作者信息
Tonnel A-B, Denis G, Lelong J
机构信息
Service de Pneumologie et Immunoallergologie, CHRU de Lille - 59037 Lille Cedex.
出版信息
Rev Mal Respir. 2006 Sep;23(4 Pt 2):10S44-10S48.
PMID:17127963
Abstract
摘要
相似文献
1
[Biotherapies for the treatment of asthma: are they the treatment of the future?].
Rev Mal Respir. 2006 Sep;23(4 Pt 2):10S44-10S48.
2
[TNF-alpha inhibitors].
Rev Prat. 2003 Nov 30;53(18):1989-90.
3
[Rheumatoid arthritis: current status of therapy].
Tunis Med. 2007 Jan;85(1):1-8.
4
[Common variable immunodeficiency and sarcoidosis: what is the link?].
Ann Ital Med Int. 2002 Apr-Jun;17(2):77-80.
5
Home therapy with subcutaneous anti-immunoglobulin-E antibody omalizumab in 25 patients with immunoglobulin-E-mediated (allergic) asthma.
J Asthma. 2007 Apr;44(3):195-6. doi: 10.1080/02770900701209749.
6
[Churg-Strauss syndrome--recent developments in diagnosis and treatment].
Dtsch Med Wochenschr. 2006 Oct 13;131(41):2270-4. doi: 10.1055/s-2006-951362.
7
[Official therapy guidelines for the family physician. Your time table in asthma].
MMW Fortschr Med. 2002 Feb 21;144(8):6-10.
8
[Anti-TNF alpha agents in vasculitis].
Med Clin (Barc). 2008 Feb 2;130(3):93-4. doi: 10.1157/13115361.
9
[Anti-TNF: beneficial or hamful for the lung?].
Tunis Med. 2009 Sep;87(9):607-9.
10
[So that the patients.would be able to move for a long time after first diagnosis of rheumatism. Approach as an emergency!].
MMW Fortschr Med. 2004 Sep 9;146(37):4-5.
Zotero 插件